Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents:; What is complementary and alternative medicine, and can it be used safely? -- Types of complementary and alternative therapies -- Herbs, vitamins, and supplements -- Symptom management with complementary and alternative medicine -- CAM therapy use by site -- Healthy living.
Contents:; 1: Basis of Carcinogenesis; 2: Epidemiology and Prevention; 3: Evidence-Based Nursing in Basic Anticancer Treatment: Management of the Most Important Side Effects; 4: The Patients? Journey with Targeted Therapies; 5: Immunotherapy: New Challenges for Nursing; 6: Robotic Surgery; 7: Relat…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.2 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
Table of contents:; The Role of Complementary Medicine and Cancer Treatment -- Communicating with Your Medical Team -- How To Use This Book -- Descriptions of Complementary Medicine Therapies -- Aromatherapy -- Chinese Medicine and Acupressure -- Herbal Teas -- Homeopathy -- Massage -- Nutrition …
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | On Loan, due Thursday, April 25, 2024 |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr Missing | Available |
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
Cancer survivorship sourcebook : basic consumer health information about the physical, educational, emotional, social, and financial needs of cancer patients from diagnosis, through cancer treatment, and beyond, including facts about researching specific types of cancer and learning about clinical …
Contents:; Physical activity and cancer survival -- Promoting physical activity for cancer survivors -- FITT principle for physical activity -- Assessing readiness for physical activity -- Assessing readiness for physical activity : physical -- Considerations -- Evaluating tolerance and adherence t…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Table of contents:; History of Cancer Immunotherapy -- Section I: Basic Principles of Tumor Immunology -- Section II: Cancer Immunotherapy Targets and Classes -- Section III: Immune Function in Cancer Patients -- Section IV: Disease-Specific Treatments and Outcomes -- Section V: Regulatory Aspects …
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Table of Contents:; I BASIC PRINCIPLES AND CONSIDERATIONS OF RATIONAL CHEMOTHERAPY AND MOLECULAR TARGETED THERAPY -- BIOLOGIC AND PHARMACOLOGIC BASIS OF CANCER CHEMOTHERAPY --BIOLOGIC BASIS OF MOLECULAR TARGETED THERAPY -- PRINCIPLES OF CANCER IMMUNOTHERAPY -- SYSTEMATIC ASSESSMENT OF THE PATIENT W…
Contents:; Cellular mechanisms of chemotherapy -- Pharmacologic principles of chemotherapy -- Pharmacogenomics and chemotherapy -- Principles and standards of antineoplastic therapy administration -- Administration of hazardous drugs in the perioperative setting -- Immunotherapy : agents and target…
Table of Contents:; Chapter 1 -- Translation in Immunology: The Role of Translational Biomarkers to Guide Clinical Use of Immunotherapy for Cancer -- Chapter 2 Monoclonal Antibody Therapy -- Chapter 3 Somatic Mutations and Immunotherapy -- Chapter 4 Checkpoint Blockade -- Chapter 5 Myeloid Leukemia…